Tumor Biology

, Volume 36, Issue 2, pp 1299–1306 | Cite as

Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer

  • Jia Zhao
  • Tianbo Liu
  • Ge Yu
  • Jing WangEmail author
Research Article


Hyaluronic acid binding protein 1 (HABP1/gC1qR/p32), a ubiquitous multifunctional protein belonging to the hyaladherin family, has been implicated in the tumorigenesis, progression, invasion, and metastasis of several malignant tumors. However, the role of HABP1 in endometrial cancer has not yet been studied. This study aimed to detect the expression of HABP1 in endometrial cancer and explore its role in the clinicopathological features and prognosis of endometrial cancer. We analyzed HABP1 expression by immunohistochemistry in 188 endometrial cancer specimens, 43 benign endometrial lesion specimens, and 41 normal endometrium specimens and assessed using Western blot analysis. Statistical analysis showed that HABP1 was overexpressed in endometrial cancer and benign endometrial lesion compared with normal endometrium (P < 0.001 and P = 0.012, respectively). In addition, HABP1 expression was significantly higher in endometrial cancer than in benign endometrial lesion (P < 0.001). High HABP1 expression was significantly associated with advanced International Federation of Gynecology and Obstetrics stage (P = 0.019), higher histologic grade (P < 0.001), deep myometrial invasion (P = 0.013), lymphovascular space invasion (P = 0.010), lymph node metastasis (P = 0.015), and recurrence (P = 0.009). Patients with high HABP1 expression had a poorer overall survival (OS) and disease-free survival (DFS) than patients with low HABP1 expression (P = 0.015 and P = 0.012, respectively). Multivariate Cox regression analysis showed that the HABP1 expression status was an independent prognostic factor of OS and DFS (P = 0.025 and P = 0.022, respectively) in patients with endometrial cancer. Our results indicated that overexpression of HABP1 may serve as a new biomarker to predict the progression and prognosis of endometrial cancer.


Hyaluronic acid binding protein 1 Endometrial carcinoma Survival Recurrence 



We gratefully acknowledge all individuals who participated in this study, especially Qi Huang and Xiang Ban for their technical assistance.

Conflicts of interest



  1. 1.
    Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975–2011. 1st ed. Bethesda: National Cancer Institute; 2014.Google Scholar
  2. 2.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.CrossRefPubMedGoogle Scholar
  3. 3.
    Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95:S105–43.CrossRefPubMedGoogle Scholar
  4. 4.
    Fowler W, Mutch D. Management of endometrial cancer. Womens Health (Lond Engl). 2008;4:479–89.CrossRefGoogle Scholar
  5. 5.
    Gupta S, Batchu RB, Datta K. Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface. Eur J Cell Biol. 1991;56:58–67.PubMedGoogle Scholar
  6. 6.
    Krainer AR, Mayeda A, Kozak D, et al. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell. 1991;66:383–94.CrossRefPubMedGoogle Scholar
  7. 7.
    Majumdar M, Datta K. Assignment of cDNA encoding hyaluronic acid binding protein 1 to human chromosome 17 p 12–13. Genomics. 1998;51:476–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Deb TB, Datta K. Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with p-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as p-32 protein, co-purified with splicing factor SF2. J Biol Chem. 1996;271:2206–12.CrossRefPubMedGoogle Scholar
  9. 9.
    Ghebrehiwet B, Lim BL, Peerschke EI, et al. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular “heads” of C1q. J Exp Med. 1994;179:1809–21.CrossRefPubMedGoogle Scholar
  10. 10.
    Matthews DA, Russell WC. Adenovirus core protein V interacts with p32–a protein which is associated with both the mitochondria and the nucleus. J Gen Virol. 1998;79:1677–85.CrossRefPubMedGoogle Scholar
  11. 11.
    Dedio J, Jahnen-Dechent W, Bachmann M, et al. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998;160:3534–42.PubMedGoogle Scholar
  12. 12.
    Muta T, Kang D, Kitajima S, et al. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997;272:24363–70.CrossRefPubMedGoogle Scholar
  13. 13.
    Majumdar M, Meenakshi J, Goswami SK, et al. Hyaluronan binding protein 1 (HABP1)/C1QBP/p32 is an endogenous substrate for MAP kinase and is translocated to the nucleus upon mitogenic stimulation. Biochem Biophys Res Commun. 2002;291:829–37.CrossRefPubMedGoogle Scholar
  14. 14.
    Kamal A, Datta K. Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis. Apoptosis. 2006;11:861–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Ghebrehiwet B, Peerschke EIB. Structure and function of gC1q-R: a multiligand binding cellular protein. Immunobiology. 1998;199:225–38.CrossRefPubMedGoogle Scholar
  16. 16.
    Soltys BJ, Kang D, Gupta RS. Localization of P32 protein (gC1q-R) in mitochondria and at specific extramitochondrial locations in normal tissues. Histochem Cell Biol. 2000;114:245–55.PubMedGoogle Scholar
  17. 17.
    Rao CM, Deb TB, Gupta S, et al. Regulation of cellular phosphorylation of hyaluronan binding protein and its role in the formation of second messenger. Biochim Biophys Acta. 1997;1336:387–93.CrossRefPubMedGoogle Scholar
  18. 18.
    Rao C, Deb TB, Datta K. Hyaluronic acid induced hyaluronic acid binding protein phosphorylation and inositol triphosphate formation in lymphocytes. Biochem Mol Biol Int. 1996;40:327–37.PubMedGoogle Scholar
  19. 19.
    Zhang X, Zhang F, Guo L, et al. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis. Mol Cell Proteomics. 2013;12:3199–209.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Chen YB, Jiang CT, Zhang GQ, et al. Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer. J Surg Oncol. 2009;100:382–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Rubinstein DB, Stortchevoi A, Boosalis M, et al. Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells. Int J Cancer. 2004;110:741–50.CrossRefPubMedGoogle Scholar
  22. 22.
    Parle-McDermott A, McWilliam P, Tighe O, et al. Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumour cell lines. Br J Cancer. 2000;83:725–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ghosh I, Chowdhury AR, Rajeswari MR, et al. Differential expression of hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma. Mol Cell Biochem. 2004;267:133–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Fogal V, Zhang L, Krajewski S, et al. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res. 2008;68:7210–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Yu H, Liu Q, Xin T, et al. Elevated expression of hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP is a novel indicator for lymph node and peritoneal metastasis of epithelial ovarian cancer patients. Tumor Biol. 2013;34:3981–7.CrossRefGoogle Scholar
  26. 26.
    Yu G, Wang J. Significance of hyaluronan binding protein (HABP1/P32/gC1qR) expression in advanced serous ovarian cancer patients. Exp Mol Pathol. 2013;94:210–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Kaul R, Saha P, Saradhi M, et al. Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway. J Biol Chem. 2012;287:19750–64.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Toole BP, Zoltan-Jones A, Misra S, et al. Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissues Organs. 2005;179:66–72.CrossRefPubMedGoogle Scholar
  29. 29.
    Meenakshi J, Goswami SK, Datta K. Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth characteristics and induces apoptosis. Biochem Biophys Res Commun. 2003;300:686–93.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Department of GynecologyThe Third Affiliated Hospital, Harbin Medical UniversityHarbinChina

Personalised recommendations